Current and projected rates of hip fracture in Canada.
PDF (161K)
Journal: 1997/December - CMAJ
ISSN: 0820-3946
PUBMED: 9371065
Abstract:
OBJECTIVE
To determine the current values and estimate the projected values (to the year 2041) for annual number of proximal femoral fractures (PFFs), age-adjusted rates of fracture, rates of death in the acute care setting, associated length of stay (LOS) in hospital, and seasonal variation by sex and age in elderly Canadians.
METHODS
Hospital discharge data for fiscal year 1993-94 from the Canadian Institute for Health Information were used to determine PFF incidence, and Statistics Canada population projections were used to estimate the rate and number of PFFs to 2041.
METHODS
Canada.
METHODS
Canadian patients 65 years of age or older who underwent hip arthroplasty.
METHODS
PFF rates, death rates and LOS by age, sex and province.
RESULTS
In 1993-94 the incidence of PFF increased exponentially with increasing age. The age-adjusted rates were 479 per 100,000 for women and 187 per 100,000 for men. The number of PFFs was estimated at 23,375 (17,823 in women and 5552 in men), with a projected increase to 88,124 in 2041. The rate of death during the acute care stay increased exponentially with increasing age. The death rates for men were twice those for women. In 1993-94 an estimated 1570 deaths occurred in the acute care setting, and 7000 deaths were projected for 2041. LOS in the acute care setting increased with advancing age, as did variability in LOS, which suggests a more heterogeneous case mix with advancing age. The LOS for 1993-94 and 2041 was estimated at 465,000 and 1.8 million patient-days respectively. Seasonal variability in the incidence of PFFs by sex was not significant. Significant season-province interactions were seen (p < 0.05); however, the differences in incidence were small (on the order of 2% to 3%) and were not considered to have a large effect on resource use in the acute care setting.
CONCLUSIONS
On the assumption that current conditions contributing to hip fractures will remain constant, the number of PFFs will rise exponentially over the next 40 years. The results of this study highlight the serious implications for Canadians if incidence rates are not reduced by some form of intervention.
Open in
PUBMED | PMC | Google Scholar | Wikipedia
Relations:
Content
Citations
(62)
References
(33)
Clinical trials
(1)
Diseases
(1)
Organisms
(1)
Processes
(1)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
CMAJ 157(10): 1357-1363
PMID: 9371065

Current and projected rates of hip fracture in Canada

Abstract

OBJECTIVE: To determine the current values and estimate the projected values (to the year 2041) for annual number of proximal femoral fractures (PFFs), age-adjusted rates of fracture, rates of death in the acute care setting, associated length of stay (LOS) in hospital, and seasonal variation by sex and age in elderly Canadians. DESIGN: Hospital discharge data for fiscal year 1993-94 from the Canadian Institute for Health Information were used to determine PFF incidence, and Statistics Canada population projections were used to estimate the rate and number of PFFs to 2041. SETTING: Canada. PARTICIPANTS: Canadian patients 65 years of age or older who underwent hip arthroplasty. OUTCOME MEASURES: PFF rates, death rates and LOS by age, sex and province. RESULTS: In 1993-94 the incidence of PFF increased exponentially with increasing age. The age-adjusted rates were 479 per 100,000 for women and 187 per 100,000 for men. The number of PFFs was estimated at 23,375 (17,823 in women and 5552 in men), with a projected increase to 88,124 in 2041. The rate of death during the acute care stay increased exponentially with increasing age. The death rates for men were twice those for women. In 1993-94 an estimated 1570 deaths occurred in the acute care setting, and 7000 deaths were projected for 2041. LOS in the acute care setting increased with advancing age, as did variability in LOS, which suggests a more heterogeneous case mix with advancing age. The LOS for 1993-94 and 2041 was estimated at 465,000 and 1.8 million patient-days respectively. Seasonal variability in the incidence of PFFs by sex was not significant. Significant season-province interactions were seen (p < 0.05); however, the differences in incidence were small (on the order of 2% to 3%) and were not considered to have a large effect on resource use in the acute care setting. CONCLUSIONS: On the assumption that current conditions contributing to hip fractures will remain constant, the number of PFFs will rise exponentially over the next 40 years. The results of this study highlight the serious implications for Canadians if incidence rates are not reduced by some form of intervention.

Full Text

The Full Text of this article is available as a PDF (161K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Phillips S, Fox N, Jacobs J, Wright WE. The direct medical costs of osteoporosis for American women aged 45 and older, 1986. Bone. 1988;9(5):271–279. [PubMed] [Google Scholar]
  • Norris RJ. Medical costs of osteoporosis. Bone. 1992;13 (Suppl 2):S11–S16. [PubMed] [Google Scholar]
  • Gallagher JC, Melton LJ, Riggs BL, Bergstrath E. Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Relat Res. 1980 Jul-Aug;(150):163–171. [PubMed] [Google Scholar]
  • Chrischilles E, Shireman T, Wallace R. Costs and health effects of osteoporotic fractures. Bone. 1994 Jul-Aug;15(4):377–386. [PubMed] [Google Scholar]
  • Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund KE, Transbøl I. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest. 1980 Aug;10(4):273–279. [PubMed] [Google Scholar]
  • Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985 Mar;102(3):319–324. [PubMed] [Google Scholar]
  • Lindsay R, Hart DM, Clark DM. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol. 1984 Jun;63(6):759–763. [PubMed] [Google Scholar]
  • Lindsay R, Tohme JF. Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol. 1990 Aug;76(2):290–295. [PubMed] [Google Scholar]
  • Murray TM. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 4. Calcium nutrition and osteoporosis. CMAJ. 1996 Oct 1;155(7):935–939.[PMC free article] [PubMed] [Google Scholar]
  • Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr. 1995 Mar;61(3 Suppl):638S–645S. [PubMed] [Google Scholar]
  • Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW, Jr, Dequeker J, Favus M. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995 Nov 30;333(22):1437–1443. [PubMed] [Google Scholar]
  • Reginster JY. Treatment of bone in elderly subjects: calcium, vitamin D, fluor, bisphosphonates, calcitonin. Horm Res. 1995;43(1-3):83–88. [PubMed] [Google Scholar]
  • Pak CY, Zerwekh JE, Antich PP, Bell NH, Singer FR. Slow-release sodium fluoride in osteoporosis. J Bone Miner Res. 1996 May;11(5):561–564. [PubMed] [Google Scholar]
  • Jaglal SB, Kreiger N, Darlington G. Past and recent physical activity and risk of hip fracture. Am J Epidemiol. 1993 Jul 15;138(2):107–118. [PubMed] [Google Scholar]
  • Fuchs-Young R, Glasebrook AL, Short LL, Draper MW, Rippy MK, Cole HW, Magee DE, Termine JD, Bryant HU. Raloxifene is a tissue-selective agonist/antagonist that functions through the estrogen receptor. Ann N Y Acad Sci. 1995 Jun 12;761:355–360. [PubMed] [Google Scholar]
  • Jaglal SB, Sherry PG, Schatzker J. The impact and consequences of hip fracture in Ontario. Can J Surg. 1996 Apr;39(2):105–111.[PMC free article] [PubMed] [Google Scholar]
  • Bagur A, Mautalen C, Rubin Z. Epidemiology of hip fractures in an urban population of central Argentina. Osteoporos Int. 1994 Nov;4(6):332–335. [PubMed] [Google Scholar]
  • Martin AD, Silverthorn KG, Houston CS, Bernhardson S, Wajda A, Roos LL. The incidence of fracture of the proximal femur in two million Canadians from 1972 to 1984. Projections for Canada in the year 2006. Clin Orthop Relat Res. 1991 May;(266):111–118. [PubMed] [Google Scholar]
  • Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev. 1985;7:178–208. [PubMed] [Google Scholar]
  • Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ., 3rd Population-based study of survival after osteoporotic fractures. Am J Epidemiol. 1993 May 1;137(9):1001–1005. [PubMed] [Google Scholar]
  • Kellie SE, Brody JA. Sex-specific and race-specific hip fracture rates. Am J Public Health. 1990 Mar;80(3):326–328.[PMC free article] [PubMed] [Google Scholar]
  • Kenzora JE, McCarthy RE, Lowell JD, Sledge CB. Hip fracture mortality. Relation to age, treatment, preoperative illness, time of surgery, and complications. Clin Orthop Relat Res. 1984 Jun;(186):45–56. [PubMed] [Google Scholar]
  • Todd CJ, Freeman CJ, Camilleri-Ferrante C, Palmer CR, Hyder A, Laxton CE, Parker MJ, Payne BV, Rushton N. Differences in mortality after fracture of hip: the east Anglian audit. BMJ. 1995 Apr 8;310(6984):904–908.[PMC free article] [PubMed] [Google Scholar]
  • Jacobsen SJ, Sargent DJ, Atkinson EJ, O'Fallon WM, Melton LJ., 3rd Population-based study of the contribution of weather to hip fracture seasonality. Am J Epidemiol. 1995 Jan 1;141(1):79–83. [PubMed] [Google Scholar]
  • Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA. Seasonal variation in the incidence of hip fracture among white persons aged 65 years and older in the United States, 1984-1987. Am J Epidemiol. 1991 May 15;133(10):996–1004. [PubMed] [Google Scholar]
  • Lewis LM, Lasater LC. Frequency, distribution, and management of injuries due to an ice storm in a large metropolitan area. South Med J. 1994 Feb;87(2):174–178. [PubMed] [Google Scholar]
  • Ralis ZA. Epidemics of fractures during periods of snow and ice. Br Med J (Clin Res Ed) 1986 Aug 23;293(6545):484–484.[PMC free article] [PubMed] [Google Scholar]
  • Rális ZA. Epidemic of fractures during period of snow and ice. Br Med J (Clin Res Ed) 1981 Feb 21;282(6264):603–605.[PMC free article] [PubMed] [Google Scholar]
  • Felson DT, Anderson JJ, Hannan MT, Milton RC, Wilson PW, Kiel DP. Impaired vision and hip fracture. The Framingham Study. J Am Geriatr Soc. 1989 Jun;37(6):495–500. [PubMed] [Google Scholar]
  • Grisso JA, Kelsey JL, Strom BL, Chiu GY, Maislin G, O'Brien LA, Hoffman S, Kaplan F. Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. N Engl J Med. 1991 May 9;324(19):1326–1331. [PubMed] [Google Scholar]
  • Kelsey JL, Hoffman S. Risk factors for hip fracture. N Engl J Med. 1987 Feb 12;316(7):404–406. [PubMed] [Google Scholar]
  • Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995 Mar 23;332(12):767–773. [PubMed] [Google Scholar]
  • Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA. Race and sex differences in mortality following fracture of the hip. Am J Public Health. 1992 Aug;82(8):1147–1150.[PMC free article] [PubMed] [Google Scholar]
Department of Nutritional Sciences, University of Toronto, Ont.
Department of Nutritional Sciences, University of Toronto, Ont.
Copyright © 1997 Canadian Medical Association

Abstract

OBJECTIVE: To determine the current values and estimate the projected values (to the year 2041) for annual number of proximal femoral fractures (PFFs), age-adjusted rates of fracture, rates of death in the acute care setting, associated length of stay (LOS) in hospital, and seasonal variation by sex and age in elderly Canadians. DESIGN: Hospital discharge data for fiscal year 1993-94 from the Canadian Institute for Health Information were used to determine PFF incidence, and Statistics Canada population projections were used to estimate the rate and number of PFFs to 2041. SETTING: Canada. PARTICIPANTS: Canadian patients 65 years of age or older who underwent hip arthroplasty. OUTCOME MEASURES: PFF rates, death rates and LOS by age, sex and province. RESULTS: In 1993-94 the incidence of PFF increased exponentially with increasing age. The age-adjusted rates were 479 per 100,000 for women and 187 per 100,000 for men. The number of PFFs was estimated at 23,375 (17,823 in women and 5552 in men), with a projected increase to 88,124 in 2041. The rate of death during the acute care stay increased exponentially with increasing age. The death rates for men were twice those for women. In 1993-94 an estimated 1570 deaths occurred in the acute care setting, and 7000 deaths were projected for 2041. LOS in the acute care setting increased with advancing age, as did variability in LOS, which suggests a more heterogeneous case mix with advancing age. The LOS for 1993-94 and 2041 was estimated at 465,000 and 1.8 million patient-days respectively. Seasonal variability in the incidence of PFFs by sex was not significant. Significant season-province interactions were seen (p < 0.05); however, the differences in incidence were small (on the order of 2% to 3%) and were not considered to have a large effect on resource use in the acute care setting. CONCLUSIONS: On the assumption that current conditions contributing to hip fractures will remain constant, the number of PFFs will rise exponentially over the next 40 years. The results of this study highlight the serious implications for Canadians if incidence rates are not reduced by some form of intervention.

Abstract
Full Text
Selected References
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.